BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
108 results:

  • 1. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-cell neuroendocrine carcinoma.
    Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
    Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small cell Lung Cancer Brain Metastases.
    Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
    Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
    Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies.
    Shimizu K; Kahramanian A; Jabbar MADA; Turna Demir F; Gokyer D; Uthamacumaran A; Rajan A; Saad MA; Gorham J; Wakimoto H; Martuza RL; Rabkin SD; Hasan T; Wakimoto H
    Cancer Lett; 2023 Sep; 572():216363. PubMed ID: 37619813
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
    Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
    World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Extracellular Vesicle-Packaged miR-195-5p Sensitizes Melanoma to Targeted Therapy with Kinase Inhibitors.
    Santos NL; Bustos SO; Reis PP; Chammas R; Andrade LNS
    Cells; 2023 May; 12(9):. PubMed ID: 37174717
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cost-Effectiveness of Pembrolizumab as an Adjuvant treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection.
    Lopez-Vinueza C; Urrego-Reyes J; Gutierrez FRS; Wurcel V; Zhang S; Jiang S; Jiang R; Zambrano Harvey A; Dhankhar P; Sawhney B; Baluni G; Jain S; Bhadra D
    Adv Ther; 2023 Jun; 40(6):2836-2854. PubMed ID: 37129772
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.
    Tichanek F; Försti A; Hemminki A; Hemminki O; Hemminki K
    Eur J Cancer; 2023 Jun; 186():133-141. PubMed ID: 37068406
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
    Wu HW; Wu CH; Lin SC; Wu CC; Chen HH; Chen YW; Lee YY; Chang FC
    Cancer Med; 2023 May; 12(9):10449-10461. PubMed ID: 36916326
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
    Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
    J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Radiotherapy and Immunotherapy in Melanoma Brain Metastases.
    Anvari A; Sasanpour P; Kheradmardi MR
    Hematol Oncol Stem Cell Ther; 2023 Jan; 16(1):1-20. PubMed ID: 36634277
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Repurposed Effect of
    Elajami MK; Burton LP; Bahmad HF; Chaaya G; Schwartz M
    Curr Oncol; 2022 Oct; 29(10):7552-7557. PubMed ID: 36290871
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma.
    Tang Q; Xu F; Lin J; Zhang C; Liu X; Dong L; Zhao J; Zhu L; Lin T
    Exp Eye Res; 2022 Nov; 224():109221. PubMed ID: 36041510
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Potential mechanisms underlying the promoting effects of 3D collagen scaffold culture on stemness and drug resistance of glioma cells.
    Jia W; Zhu H; Zhao M; Zhou Q; Yin W; Liu W; Wang L; Xiao Z; Jiang X; Dai J; Ren C
    Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166522. PubMed ID: 35981653
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.
    Schuler M; Zimmer L; Kim KB; Sosman JA; Ascierto PA; Postow MA; De Vos FYFL; van Herpen CML; Carlino MS; Johnson DB; Berking C; Reddy MB; Harney AS; Berlin JD; Amaria RN
    Clin Cancer Res; 2022 Jul; 28(14):3002-3010. PubMed ID: 35294522
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The RNA-Binding Protein Musashi1 Regulates a Network of cell Cycle Genes in Group 4 Medulloblastoma.
    Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma cells.
    Tufano M; D'Arrigo P; D'Agostino M; Giordano C; Marrone L; Cesaro E; Romano MF; Romano S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572014
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The function and mechanism of the JARID2/ccnd1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).
    Kuang W; Jiang W; Chen Y; Tian Y; Liu Z
    Cancer Biol Ther; 2021 Jun; 22(5-6):392-403. PubMed ID: 34251962
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.